Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS · Delayed Price · Currency is USD
0.000001
-0.000099 (-99.00%)
At close: Aug 27, 2026
Anthera Pharmaceuticals Market Cap
Anthera Pharmaceuticals has a market cap or net worth of $26 as of September 1, 2026.
Market Cap
26.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since March 1, 2010, Anthera Pharmaceuticals's market cap has decreased from 10.98M to 26.00, a decrease of -100.00%. That is a compound annual growth rate of -54.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 26.00 | -99.01% |
| Dec 31, 2025 | 2.62K | 9,969.23% |
| Dec 31, 2024 | 26.00 | -98.52% |
| Dec 29, 2023 | 1.75K | -33.00% |
| Dec 30, 2022 | 2.62K | -99.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Baudax Bio | 52.00 |
| Core One Labs | 47.00 |
| Mymetics | 46.00 |
| Claritas Pharmaceuticals | 38.00 |
| Intellipharmaceutics International | 33.00 |
| Rebus Holdings | 32.00 |
| Comera Life Sciences Holdings | 31.00 |
| HAVN Life Sciences | 29.00 |